These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34753834)

  • 21. Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis.
    Singh R; Kumari A
    ACS Infect Dis; 2021 Aug; 7(8):2211-2213. PubMed ID: 34328718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, cumulative mortality and factors affecting the outcome of COVID-19-associated mucormycosis from Western India.
    Vare AA; Yellambkar S; Farheen A; Nandedkar V; Bhombe SS; Shah R
    Indian J Ophthalmol; 2021 Dec; 69(12):3678-3683. PubMed ID: 34827021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19-associated mucormycosis: an epidemic within a pandemic.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2021 Oct; 114(6):355-356. PubMed ID: 34109406
    [No Abstract]   [Full Text] [Related]  

  • 26. "Black fungus": a perspective on the coronavirus disease 2019 (COVID-19)-associated rhino-orbital mucormycosis epidemic in India.
    Thakar A; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1278-1279. PubMed ID: 34185968
    [No Abstract]   [Full Text] [Related]  

  • 27. Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur VK; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Emerg Infect Dis; 2023 Jan; 29(1):8-19. PubMed ID: 36573628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.
    Gambhir RS; Aggarwal A; Bhardwaj A; Kaur A; Sohi RK; Mehta S
    Rocz Panstw Zakl Hig; 2021; 72(3):239-244. PubMed ID: 34553877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucormycosis and COVID-19: Double trouble for India?
    Yasmin F; Najeeb H; Siddiqui SA; Ochani RK
    J Glob Health; 2022; 12():03001. PubMed ID: 35154668
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors.
    Arakeri G; Patil S; Rao Us V; Amaral Mendes R; Oeppen RS; Brennan PA
    Br J Oral Maxillofac Surg; 2022 May; 60(4):e533-e534. PubMed ID: 35351328
    [No Abstract]   [Full Text] [Related]  

  • 32. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India.
    A GA; Ashraf H; HaiderMehdi HS
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.
    Mulakavalupil B; Vaity C; Joshi S; Misra A; Pandit RA
    Diabetes Metab Syndr; 2021; 15(4):102169. PubMed ID: 34198110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.
    Devnath P; Dhama K; Tareq AM; Emran TB
    Int J Surg; 2021 Aug; 92():106031. PubMed ID: 34311126
    [No Abstract]   [Full Text] [Related]  

  • 36. Using artificial intelligence-based models to predict the risk of mucormycosis among COVID-19 survivors: An experience from a public hospital in India.
    Syed-Abdul S; Babu AS; Bellamkonda RS; Itumalla R; Acharyulu G; Krishnamurthy S; Ramana YVS; Mogilicharla N; Malwade S; Li YC
    J Infect; 2022 Mar; 84(3):351-354. PubMed ID: 34953910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
    Afzal S; Nasir M
    J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.
    Gandra S; Ram S; Levitz SM
    Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and mucormycosis in Latin America - An emerging concern.
    Rodriguez-Morales AJ; Mamani-García CS; Nuñez-Lupaca JN; León-Figueroa DA; Olarte-Durand M; Yrene-Cubas RA; Ticona DM; Abanto-Urbano S
    Travel Med Infect Dis; 2021; 44():102156. PubMed ID: 34454089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.